Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Virax Holdings Ltd to acquire Pathway Oncology Pty Ltd


Sunday, 16 Mar 2014 06:05pm EDT 

Virax Holdings Ltd:Enters into binding agreement to acquire Pathway Oncology Pty Ltd (Pathway), the holder of exclusive worldwide license of certain intellectual property from Yale University and the University of South Florida.Intellectual property includes anti-cancer technology developed at Yale University in New Haven, Connecticut and the Moffitt Cancer Center in Florida.Consideration comprises: 60 mln shares on settlement, plus up to another 180 mln shares upon achievement of major value-creating milestones. 

Company Quote

0.0055
0.0010 +10.00%
19 Sep 2014